Navigation Links
Addiction Treatment Finds Success Treating Brain Deficiencies through the Belly
Date:2/19/2009

Arche Wellness, a licensed addiction treatment program near Pittsburgh PA, has found success treating addiction by focusing on patients' malfunctioning gastrointestinal (GI) tracts. Patient data demonstrates that a consistent intake of toxins causes an addict's intestines to stop the natural absorption process. As a result of its effort to decrease toxic load, the body's GI tract inhibits absorption of many essential vitamins, minerals and amino acids, which leads to severe malnutrition, deficiencies and numerous mental health issues. The center now diagnoses and treats this condition using only vitamins, minerals and amino acids, improving the program's effectiveness and increasing treatment success.

Allison Park, PA (PRWEB) February 19, 2009 -- Today Arche Wellness announced its revolutionary four-step biochemical restoration process for treating addiction. Serving individuals throughout the state of Pennsylvania, the Department of Health licensed rehabilitation center provides a medically intensive, outpatient treatment model using only vitamins, minerals and amino acids for those struggling with addiction to alcohol, heroin, methadone, buprenorphine and prescription painkillers.

The four-step system was conceived upon the realization that almost all addicts suffer from some level of gastrointestinal (GI) problems and severe malnutrition. Patient data consistently demonstrated a correlation between GI distress and non-compliance and relapse in treatment. Through laboratory testing, the program now diagnoses the status of each patient's GI tract and repairs the body's ability to fuel itself as the first stage of treatment. Through the administration of medically supervised nutrient infusions, the center restores each patient's biochemical balance and repairs the malfunctioning GI tract to resolve the root cause of drug cravings and withdrawal symptoms. Once the GI tract is functioning properly, the body adequately fuels itself resulting in faster improvement of cognitive functioning and mental health and increased effectiveness in counseling and exercise interventions.

"Many programs look at nutritional deficits in the brain, but few if any examine the malfunctions in the mechanism that fuels the brain where the deficiency actually starts - in the gut," said Erin McClelland, MS, Executive Director of the center. "Active addicts put a lot of toxins in their bodies. These toxins cause the intestines to stop absorbing in an effort to slow contamination of the body. It is a common, natural response to a high systemic toxic load. The result is a body that is not receiving the appropriate level of amino acids, vitamins and minerals. So even when patients stop using, they remain tired, anxious and depressed."

The standard intensive, eight week program includes laboratory testing and infusions, as well as supplements, substance abuse counseling, nutritional education, physical training and spiritual enhancement. "This ensures a comprehensive, complete treatment approach and leaves no issues to chance," McClelland said. To help further this goal, the program includes twelve months of continuous aftercare free of charge, which is unprecedented in the rehabilitation field.

The use of integrative medicine and the inclusion of aftercare aren't the only features that distinguish Arche Wellness from other treatment facilities. They also utilize the Toyota Production System's philosophy of continuous improvement to achieve success. In other words, the program is an ongoing cycle of planning, implementing, refining and analyzing. As a result of this process, the center will soon be offering a specialized, less expensive service for heroin and painkiller addicts under the age of 30 because data shows these patients can recover faster with less treatment. More information on this and other Arche Wellness programs is available at www.archewellness.com.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2099654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
8. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
9. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
10. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
11. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... May 20, 2016 , ... The leading Regenerative Veterinary ... most experienced veterinary clients have treated over 100 of their own patients with the ... provide the highest level of care for their patients. , The veterinarians are ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located in Ashland, Virginia is ... complete. The new structure adds a third office building to the current facilities. ... 2.4 acres of land, along with office space adjacent to the previous main building. ...
(Date:5/19/2016)... 2016 Regen BioPharma, ... RGBPP) announced today initiation of a preclinical development ... based cancer immunotherapeutic product leveraging its NR2F6 immunological ... a generation of cord blood derived killer cells ...  The product in development will be a "universal ...
(Date:5/18/2016)... 18, 2016 The Biotech industry continues ... mean that there are no opportunities ahead. Today, ActiveWallSt.com has ... THLD ), Seattle Genetics Inc. (NASDAQ: ... Ophthotech Corp. (NASDAQ: OPHT ). Sign up now ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s shares ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):